Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

Greenberg, 1993, The economic burden of depression in 1990, J Clin Psychiatry, 54, 405

Weissman, 1991, Affective disorders, 53

Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002

Depression Guideline Panel, 1993, Clinical practice guideline. Number 5. Depression in primary care: volume 1

Simon, 1998, Health care costs of primary care patients with recognized depression, Arch Gen Psychiatry, 52, 850, 10.1001/archpsyc.1995.03950220060012

Mueller, 1996, Recovery, chronicity, and levels of psychopathology in major depression, Psychiatr Clin North Am, 19, 85, 10.1016/S0193-953X(05)70275-6

Keller, 1995, Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community, Psychopharmacol Bull, 31, 205

Judd, 1998, A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders, Arch Gen Psychiatry, 55, 694, 10.1001/archpsyc.55.8.694

Thase, 1994, Refractory depression: relevance of psychosocial factors and therapies, Psychiatr Ann, 24, 232, 10.3928/0048-5713-19940501-09

Murray, 1996, Evidence-based health policy—lessons from the Global Burden of Disease Study, Science, 274, 740, 10.1126/science.274.5288.740

Wells, 1989, The functioning and well-being of depressed patients: results from the Medical Outcomes Study, JAMA, 262, 914, 10.1001/jama.1989.03430070062031

Frank, 1993, Efficacy of treatments for major depression, Psychopharmacol Bull, 29, 457

Depression Guideline Panel, 1993, Clinical practice guideline. Number 5. Depression in primary care: volume 2

Thase, 1995, Treatment-resistant depression, 1081

American Psychiatric Association, 1993, Practice guideline for major depressive disorder in adults, Am J Psychiatry, 150, 1

Rosenbaum, 2001, Treatment-resistant mood disorders, 1307

Fava, 1996, Definition and epidemiology of treatment-resistant depression, Psychiatr Clin North Am, 19, 179, 10.1016/S0193-953X(05)70283-5

Jarrett, 1994, Short-term psychotherapy of depressive disorders: current status and future directions, Psychiatry: Interpers Biol Process, 57, 115, 10.1080/00332747.1994.11024675

Frank, 1991, Conceptualization and rationale for consensus definitions of response, remission, recovery, relapse and recurrence in major depressive disorder, Arch Gen Psychiatry, 48, 851, 10.1001/archpsyc.1991.01810330075011

Riso, 1997, A prospective test of criteria for response, remission, relapse, recovery, and recurrence in patients treated with cognitive behavior therapy, J Affect Disord, 43, 131, 10.1016/S0165-0327(96)01420-6

Rush, 2002, Psychotherapies for depressive disorders: a review, Vol. 1, 161

Miller, 1998, The treatment of chronic depression, Part 3: psychosocial functioning before and after treatment with sertraline or imipramine, J Clin Psychiatry, 59, 608, 10.4088/JCP.v59n1108

Judd, 1996, Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population, Am J Psychiatry, 153, 1411, 10.1176/ajp.153.11.1411

Judd, 1997, The clinical course of unipolar major depressive disorders, Arch Gen Psychiatry, 54, 989, 10.1001/archpsyc.1997.01830230015002

Rush, 1995, Treating depression to remission, Psychiatr Ann, 25, 704, 10.3928/0048-5713-19951201-03

Van Londen, 1998, Three- to 5-year prospective follow-up of outcome in major depression, Psychol Med, 28, 731, 10.1017/S0033291797006466

Sackeim, 2000, A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities, Arch Gen Psychiatry, 57, 425, 10.1001/archpsyc.57.5.425

McCombs, 1993, Pharmacy-enforced outpatient drug treatment protocols: a case study of Medi-Cal restrictions for cefaclor, Ann Pharmacother, 27, 155, 10.1177/106002809302700203

Crismon, 1999, Texas Consensus Conference Panel: The Texas Medication Algorithm Project. Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder, J Clin Psychiatry, 60, 142, 10.4088/JCP.v60n0302

Fava, 1997, Major depressive subtypes and treatment response, Biol Psychiatry, 42, 568, 10.1016/S0006-3223(96)00440-4

Gilbert, 1998, Texas Medication Algorithm Project: definitions, rationale and methods to develop medication algorithms, J Clin Psychiatry, 59, 345, 10.4088/JCP.v59n0702

Rush, 1999, Implementing guidelines and systems of care: experiences with the Texas Medication Algorithm Project (TMAP), J Pract Psychiatry Behav Health, 5, 75, 10.1097/00131746-199903000-00002

Rush, 1999, Medication treatment of the severely and persistently mentally ill: The Texas Medication Algorithm Project, J Clin Psychiatry, 60, 142, 10.4088/JCP.v60n0503

Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56

Hamilton, 1967, Development of a rating scale for primary depressive illness, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x

Rush, 1986, The Inventory for Depressive Symptomatology (IDS): preliminary findings, Psychiatry Res, 18, 65, 10.1016/0165-1781(86)90060-0

Rush, 1996, The Inventory of Depressive Symptomatology (IDS): psychometric properties, Psychol Med, 26, 477, 10.1017/S0033291700035558

Mundt, 1997, Interactive voice response systems in clinical research and treatment, Psychiatr Serv, 48, 611, 10.1176/ps.48.5.611

Fava, 2003, Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, Vol. 26, 457

Rush, 2000, The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms, Int J Methods Psychiatric Res, 9, 45, 10.1002/mpr.79

Rush, 2003, The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol Psychiatry, 54, 573, 10.1016/S0006-3223(02)01866-8

Trivedi MH, Ibrahim HM, Carmody TC, et al. A psychometric evaluation of the Quick Inventory of Depressive Symptomatology (QIDS) in public sector patients with mood disorders. Psychol Med, [in press].

Jarrett, 2001, Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial, Arch Gen Psychiatry, 58, 381, 10.1001/archpsyc.58.4.381

Shaw, 1984, Specification of the training and evaluation of cognitive therapists for outcome studies, 173

American Psychiatric Association, 1994

World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964; and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975; 35th WMA General Assembly, Venice, Italy, October 1983; 41st WMA General Assembly, Hong Kong, September 1989; 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996; and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington; 2002.

Zimmerman, 1999, The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients, J Clin Psychiatry, 60, 677, 10.4088/JCP.v60n1006

Linn, 1968, The cumulative illness rating scale, J Am Geriatr Soc, 16, 622, 10.1111/j.1532-5415.1968.tb02103.x

Fava, 1998, Prevention of recurrent depression with cognitive therapy: preliminary findings, Arch Gen Psychiatry, 55, 816, 10.1001/archpsyc.55.9.816

Paykel, 1999, Prevention of relapse in residual depression by cognitive therapy. A controlled trial, Arch Gen Psychiatry, 56, 829, 10.1001/archpsyc.56.9.829

Guy, 1976

Ware, 1996, A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity, Med Care, 34, 220, 10.1097/00005650-199603000-00003

Mundt, 2002, The work and social adjustment scale: a simple measure of impairment in functioning, Br J Psychiatry, 180, 461, 10.1192/bjp.180.5.461

Reilly, 1993, The validity and reproducibility of a work productivity and activity impairment instrument, Pharmacoeconomics, 4, 353, 10.2165/00019053-199304050-00006

Endicott, 1993, Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q): a new measure, Psychopharmacol Bull, 29, 321

Kashner, 1998, Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs, Med Care, 36, 1324, 10.1097/00005650-199809000-00005

Clark, 1996, Measuring hospital use without claims: a comparison of patient and provider reports, Health Serv Res, 31, 153

Dresser, 1997, Clinical quality measurement: comparing chart review and automated methodologies, Med Care, 35, 539, 10.1097/00005650-199706000-00001

Kashner, 1992, An analysis of panel data: the impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder, Med Care, 30, 811, 10.1097/00005650-199209000-00005

Magaziner, 1988, Patient-proxy response comparability on measures of patient health and functional status, J Clin Epidemiol, 41, 1065, 10.1016/0895-4356(88)90076-5

Quam, 1993, Using claims data for epidemiologic research: the concordance of claim-based criteria with the medical record and patient survey for identifying a hypertensive population, Med Care, 31, 498, 10.1097/00005650-199306000-00003

Kobak, 1999, Computerized assessment of depression and anxiety over the telephone using Interactive Voice Response, MD Comput, 16, 64

Kobak, 1996, Computer-administered clinical rating scales: a review, Psychopharmacology, 127, 291, 10.1007/s002130050089

Rice, 1985, The economic costs of illness: a replication and update, Health Care Financ Rev, 7, 61

Rice, 1993, Economic burden of affective disorders, Vol. 14, 37

Rice, 1999, Economic burden of mental disorders in the United States, TEN: The Economics of Neuroscience, 1, 40

Stoudemire, 1986, The economic burden of depression, Gen Hosp Psychiatry, 8, 387, 10.1016/0163-8343(86)90018-6

Lavori, 2001, Strengthening clinical effectiveness trials: equipoise-stratified randomization, Biol Psychiatry, 50, 792, 10.1016/S0006-3223(01)01223-9

Cohen, 1988

Duan, 1983, A comparison of alternative models for the demand for medical care, J Bus Econ Stat, 1, 115, 10.2307/1391852

Pohlmeier, 1995, An econometric model of the two-part process in the demand for health, J Hum Resour, 30, 339, 10.2307/146123

Maddala, 1988

Rush, 1999, Linking efficacy and effectiveness research in the evaluation of psychotherapies, 26